Daiwa Securities Group’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-110
Closed 1371
2022
Q3
$0 Hold
110
﹤0.01% 1381
2022
Q2
$0 Hold
110
﹤0.01% 1405
2022
Q1
$1K Hold
110
﹤0.01% 1330
2021
Q4
$2K Hold
110
﹤0.01% 1290
2021
Q3
$2K Buy
110
+59
+116% +$1.07K ﹤0.01% 1244
2021
Q2
$1K Hold
51
﹤0.01% 1207
2021
Q1
$1K Hold
51
﹤0.01% 1221
2020
Q4
$1K Buy
+51
New +$1K ﹤0.01% 1200